A fraud investigation linked to AstraZeneca (NASDAQ:AZN) has expanded to several government agencies, implicating dozens of senior executives at the company as of last week, Shanghai-based business ...

The 13-year veteran is teaming up with AstraZeneca for their Get Body Checked Against Cancer public health campaign.

At the ObesityWeek 2024, AstraZeneca Plc (NASDAQ:AZN) shared data abstracts highlighting early data from AZD5004/ECC5004. In ...

AstraZeneca’s drug Fasenra gets an expanded indication in the EU and is now approved as a treatment for the rare autoimmune disease known as Churg-Strauss syndrome.

Anaheim Ducks forward Alex Killorn heaped praise on teammate Leo Carlsson as he says he surprises him everyday with how good ...

SLE is a chronic and complex heterogeneous autoimmune disease in which the immune system dysfunctions and inappropriately ...

Vutrisiran MarketThe global vutrisiran market, valued at USD 600 million in 2022, is expected to experience substantial growth, reaching an estimated USD 2,087 million by 2033, with a compound annual ...

Patients with advanced bladder cancer that had spread to other parts of the body (metastasised) have responded well in a ...

(IN BRIEF) AstraZeneca presented significant advancements in the prevention of infectious diseases at IDWeek 2024, showcasing its dedication to addressing respiratory infections caused by RSV, hMPV, ...

Get ready for an exciting new chapter of the United States vs. Mexico rivalry! With recent coaching changes bringing a high-profile figure in Mauricio Pochettino to the U.S. men's national team ...

FluMist is an efficacious and safely tolerated intranasal influenza vaccine. FluMist has gained approval from the FDA for self-administration by patients aged 18-49. FluMist is the first influenza ...

It was better than it's been in a long while, though, and that's a good place to start. Follow USA TODAY Sports columnist Nancy Armour on social media @nrarmour.